Adaptyv Biosystems - About the company
Adaptyv Biosystems is a seed company based in Lausanne (Switzerland), founded in 2021 by Daniel Nakhaee Zadeh Gutierrez, Moustafa Houmani and Julian Englert. It operates as a Provider of protein design, synthesis, testing, and validation services. Adaptyv Biosystems has raised $2.62M in funding from Y Combinator and Founderful. The company has 44 active competitors, including 12 funded and 7 that have exited. Its top competitors include companies like 64x Bio, Phoremost and Molcure.
Company Details
Provider of protein design, synthesis, testing, and validation services. It offers a platform for generating experimental data to improve protein designs. The company streamlines protein expression and enables synthesis of designed proteins. Automated workcells profile protein designs for functions and interactions to generate experimental data.
- Website
- www.adaptyvbio.com/
- Email ID
- *****@adaptyvbio.com
- Phone Number
- +41 **********
- Registered Address
- 251 Little Falls Drive, Wilmington, DE
Key Metrics
Founded Year
2021
Location
Lausanne, Switzerland
Stage
Seed
Total Funding
$2.62M in 4 rounds
Latest Funding Round
Investors
Ranked
5th among 44 active competitors
Employee Count
32 as on Mar 31, 2026
Similar Companies
Legal entities associated with Adaptyv Biosystems
Adaptyv Biosystems is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Adaptyv Biosystems Inc CIN: 0001894760 , United States, Active | - | - | - |
Sign up to download Adaptyv Biosystems' company profile
Adaptyv Biosystems's funding and investors
Adaptyv Biosystems has raised a total funding of $2.62M over 4 rounds. Its first funding round was on Apr 28, 2021. Its latest funding round was a Seed round on Feb 14, 2022 for $*****. 11 investors participated in its latest round. Adaptyv Biosystems has 14 institutional investors.
Here is the list of recent funding rounds of Adaptyv Biosystems:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Feb 14, 2022 | 5246310 | Seed | 2710752 | 2522904 | 2743833 | 9857533 |
Aug 04, 2021 | 2762235 | Seed | 7409192 | 2352356 | 3404975 | 2561885 |
Jul 01, 2021 | 6628206 | Grant (prize money) | 8557045 | 9064908 | 2309066 |
View details of Adaptyv Biosystems's funding rounds and investors
Adaptyv Biosystems' founders and board of directors
Founder? Claim ProfileThe founders of Adaptyv Biosystems are Daniel Nakhaee Zadeh Gutierrez, Moustafa Houmani and Julian Englert.
Here are the details of Adaptyv Biosystems' key team members:
- Daniel Nakhaee Zadeh Gutierrez: Co-Founder of Adaptyv Biosystems. Contact Info: 1 email address
- Moustafa Houmani: Co-Founder of Adaptyv Biosystems.
- Julian Englert: Co-Founder of Adaptyv Biosystems. Contact Info: 1 email address
View details of Adaptyv Biosystems's Founder profiles and Board Members
Adaptyv Biosystems' employee count trend
Adaptyv Biosystems has 32 employees as of Mar 26. Here is Adaptyv Biosystems's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Adaptyv Biosystems's Competitors and alternates
Top competitors of Adaptyv Biosystems include 64x Bio, Phoremost and Molcure. Here is the list of Top 10 competitors of Adaptyv Biosystems, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | 64x Bio 2017, San Francisco (United States), Series A | Developer of cell lines and production technologies for advanced therapies | $59.6M | 60/100 | |
2nd | Phoremost 2015, Cambridge (United Kingdom), Series B | Developer of a phenotypic screening platform for drug target discovery | $76.8M | 56/100 | |
3rd | Provider of AI-based platform for drug discovery and design | $11.7M | 53/100 | ||
4th | Developer of a drug pipeline programs for neurodegenerative diseases | $29.1M | 51/100 | ||
5th | Adaptyv Biosystems 2021, Lausanne (Switzerland), Seed | Provider of protein design, synthesis, testing, and validation services | $2.62M | 52/100 | |
6th | Rheonix 2008, Ithaca (United States), Series B | Provider of instruments for automated assays | $72.7M | 49/100 | |
7th | Beacon Discovery 2016, San Diego (United States), Acquired | Develops assay platforms to identify GPCR based therapeutics | - | - | 43/100 |
8th | AimedBio 2018, Seoul (South Korea), Public | Developer of screening platform for brain drug discovery and efficacy | - | - | 42/100 |
9th | Developed platform for the screening of therapeutic peptides | - | - | 40/100 | |
10th | Modular Genetics 2000, Woburn (United States), Series B | Developer of a proprietary, automated system for gene engineering and molecular biology | $8.9M | 38/100 |
Looking for more details on Adaptyv Biosystems's competitors? Click here to see the top ones
Adaptyv Biosystems's Investments and acquisitions
Adaptyv Biosystems has made no investments or acquisitions yet.
News related to Adaptyv Biosystems
Media has covered Adaptyv Biosystems for 1 event in last 1 year, It was about company updates.
•
•
Adaptyv Biosytems launches protein engineering foundryEuropean Biotechnology•Apr 13, 2023•Adaptyv Biosystems
•
•
•
Are you a Founder ?
FAQs about Adaptyv Biosystems
Explore our recently published companies
- StarZing - Mumbai based, 2007 founded, Funding Raised company
- ZEO Technology - Pamplona based, 2021 founded, Unfunded company
- MHE Bazar - India based, Unfunded company
- Crystic Resins - Faridabad based, 1968 founded, Funding Raised company
- LenderCloud - Rye based, 2011 founded, Unfunded company
- Syniris - Pune based, 2025 founded, Unfunded company
